Compounds developed through collaboration with Variational AI show targeted activity
Rakovina Therapeutics KT-5000AI Program Yields Potent ATR Inhibitor Hits in Early Screening
Seeking Alpha / 3 hours ago 2 Views
Compounds developed through collaboration with Variational AI show targeted activity
Comments